An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides

Abstract

sv6D is a functional ligand for CLEC10A and induces maturation of immune cells in the peritoneal cavity. The peptide caused a highly significant extension of survival of mice with implanted ovarian cancer cells with a favorable toxicity and non-antigenic profile.